{"transactions":[{"id":1575057,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-03-15T23:14:06.000Z","date":"2024-01-10","kind":"sale","planned":true,"acquired":false,"shares":31614,"price":13.6475,"value":431452.065,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.48 to $13.96 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On January 11, 2024, the reporting person filed a Form 4 which inadvertently excluded the acquisition of shares granted for the achievement of the TSR portion of the 2021 PRSU award and inadvertently reported incorrect holdings following both shares being withheld for taxes and a sale transaction. This Form 4 amendment reflects these transactions and the reporting person's holdings following these transactions correctly."}],"balance_after":927013,"source":{"system":"sec-edgar","filing":"0000950170-24-032406","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024032406/ownership.xml","form_type":"4/A","original_submission_date":"2024-01-11"}},{"id":1575056,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-03-15T23:14:06.000Z","date":"2024-01-09","kind":"tax_withholding","planned":true,"acquired":false,"shares":36865,"price":13.65,"value":503207.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On January 11, 2024, the reporting person filed a Form 4 which inadvertently excluded the acquisition of shares granted for the achievement of the TSR portion of the 2021 PRSU award and inadvertently reported incorrect holdings following both shares being withheld for taxes and a sale transaction. This Form 4 amendment reflects these transactions and the reporting person's holdings following these transactions correctly."}],"balance_after":958627,"source":{"system":"sec-edgar","filing":"0000950170-24-032406","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024032406/ownership.xml","form_type":"4/A","original_submission_date":"2024-01-11"}},{"id":1575055,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-03-15T23:14:06.000Z","date":"2024-01-09","kind":"grant","planned":true,"acquired":true,"shares":57620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Granted for the achievement of the 2021 PRSU TSR goal as determined by the Compensation and Leadership Development Committee of the Board of Directors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On January 11, 2024, the reporting person filed a Form 4 which inadvertently excluded the acquisition of shares granted for the achievement of the TSR portion of the 2021 PRSU award and inadvertently reported incorrect holdings following both shares being withheld for taxes and a sale transaction. This Form 4 amendment reflects these transactions and the reporting person's holdings following these transactions correctly."}],"balance_after":995492,"source":{"system":"sec-edgar","filing":"0000950170-24-032406","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024032406/ownership.xml","form_type":"4/A","original_submission_date":"2024-01-11"}},{"id":1597965,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-03-05T22:14:13.000Z","date":"2024-03-01","kind":"sale","planned":true,"acquired":false,"shares":29181,"price":13.3492,"value":389543.0052,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.04 to $13.58 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":573478,"source":{"system":"sec-edgar","filing":"0000950170-24-026265","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024026265/ownership.xml","form_type":"4"}},{"id":1634445,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-02-20T22:23:21.000Z","date":"2024-02-15","kind":"tax_withholding","planned":true,"acquired":false,"shares":94969,"price":14,"value":1329566.0,"ownership":{"direct":true},"balance_after":602659,"source":{"system":"sec-edgar","filing":"0000950170-24-017264","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024017264/ownership.xml","form_type":"4"}},{"id":1634444,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-02-20T22:23:21.000Z","date":"2024-02-15","kind":"sale","planned":true,"acquired":false,"shares":31614,"price":13.8088,"value":436551.4032,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.36 to $14.02 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":697628,"source":{"system":"sec-edgar","filing":"0000950170-24-017264","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024017264/ownership.xml","form_type":"4"}},{"id":1659403,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-02-06T00:22:04.000Z","date":"2024-02-01","kind":"tax_withholding","planned":true,"acquired":false,"shares":21596,"price":12.67,"value":273621.32,"ownership":{"direct":true},"balance_after":729242,"source":{"system":"sec-edgar","filing":"0000950170-24-011433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024011433/ownership.xml","form_type":"4"}},{"id":1659402,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-02-06T00:22:04.000Z","date":"2024-02-01","kind":"sale","planned":true,"acquired":false,"shares":31614,"price":12.6184,"value":398918.0976,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.44 to $12.74 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":750838,"source":{"system":"sec-edgar","filing":"0000950170-24-011433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024011433/ownership.xml","form_type":"4"}},{"id":1672254,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-01-24T22:20:54.000Z","date":"2024-01-22","kind":"sale","planned":true,"acquired":false,"shares":55327,"price":12.3621,"value":683957.9067,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.10 to $12.57 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":782452,"source":{"system":"sec-edgar","filing":"0000950170-24-007065","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024007065/ownership.xml","form_type":"4"}},{"id":1676715,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-01-18T22:09:26.000Z","date":"2024-01-16","kind":"sale","planned":true,"acquired":false,"shares":31614,"price":12.7825,"value":404105.955,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.68 to $12.92 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":837779,"source":{"system":"sec-edgar","filing":"0000950170-24-005451","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024005451/ownership.xml","form_type":"4"}},{"id":1680920,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-01-11T23:33:44.000Z","date":"2024-01-10","kind":"sale","planned":true,"acquired":false,"shares":31614,"price":13.6475,"value":431452.065,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.48 to $13.96 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":869393,"source":{"system":"sec-edgar","filing":"0000950170-24-004042","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024004042/ownership.xml","form_type":"4"}},{"id":1680919,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-01-11T23:33:44.000Z","date":"2024-01-09","kind":"tax_withholding","planned":true,"acquired":false,"shares":36865,"price":13.65,"value":503207.25,"ownership":{"direct":true},"balance_after":901007,"source":{"system":"sec-edgar","filing":"0000950170-24-004042","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024004042/ownership.xml","form_type":"4"}},{"id":1685819,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-01-05T23:02:40.000Z","date":"2024-01-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":10659,"price":13.44,"value":143256.96,"ownership":{"direct":true},"balance_after":937872,"source":{"system":"sec-edgar","filing":"0000950170-24-002582","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024002582/ownership.xml","form_type":"4"}},{"id":1688489,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Options (right to buy)","published_at":"2024-01-04T23:33:06.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":249665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant."}],"balance_after":249665,"derivative":{"exercise_price":14.24,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":249665},"source":{"system":"sec-edgar","filing":"0000950170-24-002130","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024002130/ownership.xml","form_type":"4"}},{"id":1688488,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-01-04T23:33:06.000Z","date":"2024-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":108417,"price":13.53,"value":1466882.01,"ownership":{"direct":true},"balance_after":948531,"source":{"system":"sec-edgar","filing":"0000950170-24-002130","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024002130/ownership.xml","form_type":"4"}},{"id":1688487,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-01-04T23:33:06.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":144628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted in the form of Restricted Stock Units (\"RSUs\"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock."}],"balance_after":1056948,"source":{"system":"sec-edgar","filing":"0000950170-24-002130","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017024002130/ownership.xml","form_type":"4"}},{"id":1705331,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-12-19T22:55:59.000Z","date":"2023-12-18","kind":"grant","planned":true,"acquired":true,"shares":34572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a contingent right to receive common stock in the amount shown, for no consideration, due to the satisfaction of performance criteria underlying an award of performance based restricted stock units granted in 2021. Such units remain outstanding on the date hereof and will fully vest on December 31, 2023, subject to the Reporting Person's continued service with the Company."}],"balance_after":912320,"source":{"system":"sec-edgar","filing":"0000950170-23-071631","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017023071631/ownership.xml","form_type":"4"}},{"id":1705330,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-12-19T22:55:59.000Z","date":"2023-12-15","kind":"sale","planned":true,"acquired":false,"shares":6043,"price":12.6619,"value":76515.8617,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.51 to $12.83 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":877748,"source":{"system":"sec-edgar","filing":"0000950170-23-071631","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017023071631/ownership.xml","form_type":"4"}},{"id":1722242,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-12-05T22:03:42.000Z","date":"2023-12-01","kind":"sale","planned":true,"acquired":false,"shares":6043,"price":11.08,"value":66956.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.88 to $11.21 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":883791,"source":{"system":"sec-edgar","filing":"0000950170-23-068254","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017023068254/ownership.xml","form_type":"4"}},{"id":1737290,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-11-17T22:23:46.000Z","date":"2023-11-15","kind":"sale","planned":true,"acquired":false,"shares":6043,"price":10.8385,"value":65497.0555,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.66 to $11.17 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":889834,"source":{"system":"sec-edgar","filing":"0000950170-23-064910","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017023064910/ownership.xml","form_type":"4"}},{"id":1750095,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-11-03T23:37:40.000Z","date":"2023-11-01","kind":"sale","planned":true,"acquired":false,"shares":6044,"price":10.9741,"value":66327.4604,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.865 to $11.08 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":895877,"source":{"system":"sec-edgar","filing":"0000950170-23-058953","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017023058953/ownership.xml","form_type":"4"}},{"id":1758280,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-10-18T23:57:22.000Z","date":"2023-10-16","kind":"sale","planned":true,"acquired":false,"shares":6044,"price":10.4979,"value":63449.3076,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.27 to $10.61 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":901921,"source":{"system":"sec-edgar","filing":"0000950170-23-054012","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000095017023054012/ownership.xml","form_type":"4"}},{"id":1765655,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-10-04T22:58:50.000Z","date":"2023-10-02","kind":"sale","planned":true,"acquired":false,"shares":1600,"price":11.7075,"value":18732.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.51 to $12.10 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":907965,"source":{"system":"sec-edgar","filing":"0001209191-23-052110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123052110/doc4.xml","form_type":"4"}},{"id":1765654,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-10-04T22:58:50.000Z","date":"2023-10-02","kind":"sale","planned":true,"acquired":false,"shares":4444,"price":11.079,"value":49235.076,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.95 to $11.47 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":909565,"source":{"system":"sec-edgar","filing":"0001209191-23-052110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123052110/doc4.xml","form_type":"4"}},{"id":1779194,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-09-18T21:09:21.000Z","date":"2023-09-15","kind":"sale","planned":true,"acquired":false,"shares":6044,"price":13.0648,"value":78963.6512,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.93 to $13.22 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":914009,"source":{"system":"sec-edgar","filing":"0001209191-23-049782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123049782/doc4.xml","form_type":"4"}},{"id":1787567,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-09-06T21:31:02.000Z","date":"2023-09-01","kind":"sale","planned":true,"acquired":false,"shares":6044,"price":12.9794,"value":78447.4936,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.88 to $13.14 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":920053,"source":{"system":"sec-edgar","filing":"0001209191-23-048461","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123048461/doc4.xml","form_type":"4"}},{"id":1806140,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-08-16T21:33:45.000Z","date":"2023-08-15","kind":"sale","planned":true,"acquired":false,"shares":6044,"price":13.0268,"value":78733.9792,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.94 to $13.28 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":926097,"source":{"system":"sec-edgar","filing":"0001209191-23-046081","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123046081/doc4.xml","form_type":"4"}},{"id":1816678,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-08-03T21:10:16.000Z","date":"2023-08-01","kind":"sale","planned":true,"acquired":false,"shares":6044,"price":13.3548,"value":80716.4112,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.22 to $13.48 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":932141,"source":{"system":"sec-edgar","filing":"0001209191-23-044494","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123044494/doc4.xml","form_type":"4"}},{"id":1827028,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-07-19T21:45:34.000Z","date":"2023-07-17","kind":"sale","planned":true,"acquired":false,"shares":6044,"price":13.4453,"value":81263.3932,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.32 to $13.70 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":938185,"source":{"system":"sec-edgar","filing":"0001209191-23-042773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123042773/doc4.xml","form_type":"4"}},{"id":1834210,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-07-06T22:26:16.000Z","date":"2023-07-03","kind":"sale","planned":true,"acquired":false,"shares":6044,"price":12.3107,"value":74405.8708,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.26 to $12.46 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":944229,"source":{"system":"sec-edgar","filing":"0001209191-23-041658","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123041658/doc4.xml","form_type":"4"}},{"id":1850098,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-06-20T21:18:34.000Z","date":"2023-06-15","kind":"sale","planned":true,"acquired":false,"shares":6044,"price":13.04,"value":78813.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.86 to $13.35 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":950273,"source":{"system":"sec-edgar","filing":"0001209191-23-038515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123038515/doc4.xml","form_type":"4"}},{"id":1852194,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T20:26:58.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":6473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 14, 2023 with respect to 6,473 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":6473,"derivative":{"exercise_price":45.2,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":6473},"source":{"system":"sec-edgar","filing":"0001209191-23-037879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123037879/doc4.xml","form_type":"4"}},{"id":1852193,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:26:58.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":4425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":11716,"source":{"system":"sec-edgar","filing":"0001209191-23-037879","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123037879/doc4.xml","form_type":"4"}},{"id":1858824,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T20:06:09.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) the one-year anniversary of June 8, 2023 (the \"Vesting Start Date\") or (ii) the Issuer's next annual meeting of stockholders."}],"balance_after":16000,"derivative":{"exercise_price":14.67,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001104659-23-070332","document":"tm2318445-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689375/000110465923070332/tm2318445-2_4seq1.xml","form_type":"4"}},{"id":1867574,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-06-05T23:16:52.000Z","date":"2023-06-01","kind":"sale","planned":true,"acquired":false,"shares":6044,"price":11.3596,"value":68657.4224,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.08 to $11.51 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":956317,"source":{"system":"sec-edgar","filing":"0001209191-23-034638","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123034638/doc4.xml","form_type":"4"}},{"id":1889612,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-05-17T22:20:28.000Z","date":"2023-05-15","kind":"sale","planned":true,"acquired":false,"shares":6044,"price":11.1808,"value":67576.7552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.93 to $11.44 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":962361,"source":{"system":"sec-edgar","filing":"0001209191-23-030378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123030378/doc4.xml","form_type":"4"}},{"id":1906452,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-05-03T20:35:34.000Z","date":"2023-05-01","kind":"sale","planned":true,"acquired":false,"shares":6044,"price":11.8026,"value":71334.9144,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.59 to $11.89 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":968405,"source":{"system":"sec-edgar","filing":"0001062993-23-010103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000106299323010103/form4.xml","form_type":"4"}},{"id":1917354,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-04-19T21:45:16.000Z","date":"2023-04-17","kind":"sale","planned":true,"acquired":false,"shares":6044,"price":11.6648,"value":70502.0512,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.50 to $11.91 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":974449,"source":{"system":"sec-edgar","filing":"0001209191-23-024884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123024884/doc4.xml","form_type":"4"}},{"id":1925455,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-04-06T00:26:34.000Z","date":"2023-04-03","kind":"sale","planned":true,"acquired":false,"shares":6044,"price":11.2156,"value":67787.0864,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.10 to $11.34 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":980493,"source":{"system":"sec-edgar","filing":"0001209191-23-023529","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123023529/doc4.xml","form_type":"4"}},{"id":1947707,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-03-17T22:39:16.000Z","date":"2023-03-15","kind":"sale","acquired":false,"shares":6044,"price":11.3414,"value":68547.4216,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.23 to $11.50 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":986537,"source":{"system":"sec-edgar","filing":"0001209191-23-019892","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123019892/doc4.xml","form_type":"4"}},{"id":1974919,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-03-03T22:46:24.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":1937,"price":13.6862,"value":26510.1694,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.64 to $13.78 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":992581,"source":{"system":"sec-edgar","filing":"0001209191-23-015842","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123015842/doc4.xml","form_type":"4"}},{"id":1974918,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-03-03T22:46:24.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":4107,"price":13.2902,"value":54582.8514,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.64 to $13.63 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":994518,"source":{"system":"sec-edgar","filing":"0001209191-23-015842","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123015842/doc4.xml","form_type":"4"}},{"id":2011393,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-02-16T22:49:23.000Z","date":"2023-02-15","kind":"sale","acquired":false,"shares":6044,"price":12.9413,"value":78217.2172,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.36 to $13.34 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":998625,"source":{"system":"sec-edgar","filing":"0001209191-23-010214","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123010214/doc4.xml","form_type":"4"}},{"id":2033535,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Options (right to buy)","published_at":"2023-02-03T22:46:35.000Z","date":"2023-02-01","kind":"exercise","acquired":false,"shares":56596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of these options were fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":5.13,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":56596},"source":{"system":"sec-edgar","filing":"0001209191-23-007119","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123007119/doc4.xml","form_type":"4"}},{"id":2033534,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Options (right to buy)","published_at":"2023-02-03T22:46:35.000Z","date":"2023-02-01","kind":"exercise","acquired":false,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of these options were fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":6.1,"expiration_date":"2026-06-15","underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001209191-23-007119","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123007119/doc4.xml","form_type":"4"}},{"id":2033533,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-02-03T22:46:35.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":147316,"price":13.1102,"value":1931342.2232,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 7, 2022 for estate planning purposes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.81 to $13.28 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1004669,"source":{"system":"sec-edgar","filing":"0001209191-23-007119","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123007119/doc4.xml","form_type":"4"}},{"id":2033532,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-02-03T22:46:35.000Z","date":"2023-02-01","kind":"exercise","acquired":true,"shares":56596,"price":5.13,"value":290337.48,"ownership":{"direct":true},"balance_after":1151985,"source":{"system":"sec-edgar","filing":"0001209191-23-007119","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123007119/doc4.xml","form_type":"4"}},{"id":2033531,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-02-03T22:46:35.000Z","date":"2023-02-01","kind":"exercise","acquired":true,"shares":83333,"price":6.1,"value":508331.3,"ownership":{"direct":true},"balance_after":1095389,"source":{"system":"sec-edgar","filing":"0001209191-23-007119","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123007119/doc4.xml","form_type":"4"}},{"id":2054900,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-01-13T22:14:16.000Z","date":"2023-01-11","kind":"tax_withholding","acquired":false,"shares":83261,"price":12.02,"value":1000797.22,"ownership":{"direct":true},"balance_after":1012056,"source":{"system":"sec-edgar","filing":"0001209191-23-003305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123003305/doc4.xml","form_type":"4"}},{"id":2054899,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-01-13T22:14:16.000Z","date":"2023-01-11","kind":"grant","acquired":true,"shares":210088,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Granted for the achievement of the 2020 PRSU TSR goal as determined by the Compensation and Leadership Development Committee of the Board of Directors."}],"balance_after":1095317,"source":{"system":"sec-edgar","filing":"0001209191-23-003305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123003305/doc4.xml","form_type":"4"}},{"id":2056670,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-01-12T02:01:35.000Z","date":"2023-01-09","kind":"sale","acquired":false,"shares":85102,"price":11.4328,"value":972954.1456,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.24 to $11.74 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":885229,"source":{"system":"sec-edgar","filing":"0001209191-23-003083","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123003083/doc4.xml","form_type":"4"}},{"id":2060768,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-01-06T22:04:01.000Z","date":"2023-01-04","kind":"tax_withholding","acquired":false,"shares":10659,"price":12.03,"value":128227.77,"ownership":{"direct":true},"balance_after":970331,"source":{"system":"sec-edgar","filing":"0001209191-23-002395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123002395/doc4.xml","form_type":"4"}},{"id":2068748,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Options (right to buy)","published_at":"2023-01-05T00:16:27.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":414025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant."}],"balance_after":414025,"derivative":{"exercise_price":11.93,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":414025},"source":{"system":"sec-edgar","filing":"0001209191-23-001400","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123001400/doc4.xml","form_type":"4"}},{"id":2068747,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-01-05T00:16:27.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":233248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Granted in the form of Restricted Stock Units (\"RSUs\"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock."}],"balance_after":980990,"source":{"system":"sec-edgar","filing":"0001209191-23-001400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123001400/doc4.xml","form_type":"4"}},{"id":2068746,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-01-05T00:16:27.000Z","date":"2023-01-03","kind":"tax_withholding","acquired":false,"shares":22116,"price":11.93,"value":263843.88,"ownership":{"direct":true},"balance_after":747742,"source":{"system":"sec-edgar","filing":"0001209191-23-001400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123001400/doc4.xml","form_type":"4"}},{"id":2068745,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-01-05T00:16:27.000Z","date":"2023-01-02","kind":"tax_withholding","acquired":false,"shares":21596,"price":12.21,"value":263687.16,"ownership":{"direct":true},"balance_after":769858,"source":{"system":"sec-edgar","filing":"0001209191-23-001400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919123001400/doc4.xml","form_type":"4"}},{"id":2082146,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2022-12-19T23:16:58.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":10468,"price":12.1486,"value":127171.5448,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.96 to $12.34 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":791454,"source":{"system":"sec-edgar","filing":"0001209191-22-062014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122062014/doc4.xml","form_type":"4"}},{"id":2096564,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2022-12-05T23:15:08.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":11347,"price":12.2035,"value":138473.1145,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.98 to $12.31 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":801922,"source":{"system":"sec-edgar","filing":"0001209191-22-059829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122059829/doc4.xml","form_type":"4"}},{"id":2112678,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2022-11-17T22:10:40.000Z","date":"2022-11-15","kind":"sale","acquired":false,"shares":10468,"price":11.6418,"value":121866.3624,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.45 to $11.79 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":813269,"source":{"system":"sec-edgar","filing":"0001209191-22-057594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122057594/doc4.xml","form_type":"4"}},{"id":2125964,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2022-11-04T00:03:18.000Z","date":"2022-11-01","kind":"sale","acquired":false,"shares":11346,"price":10.3166,"value":117052.1436,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $9.90 to $10.47 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":823737,"source":{"system":"sec-edgar","filing":"0001209191-22-055675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122055675/doc4.xml","form_type":"4"}},{"id":2134897,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2022-10-19T22:43:26.000Z","date":"2022-10-17","kind":"sale","acquired":false,"shares":10468,"price":10.9045,"value":114148.306,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.66 to $11.03 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":835083,"source":{"system":"sec-edgar","filing":"0001209191-22-054130","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122054130/doc4.xml","form_type":"4"}},{"id":2142609,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2022-10-05T21:43:59.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":11346,"price":10.7462,"value":121926.3852,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.46 to $10.99 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":845551,"source":{"system":"sec-edgar","filing":"0001209191-22-052856","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122052856/doc4.xml","form_type":"4"}},{"id":2156140,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2022-09-19T23:56:05.000Z","date":"2022-09-15","kind":"sale","acquired":false,"shares":10468,"price":10.6637,"value":111627.6116,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.22 to $10.96 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":856897,"source":{"system":"sec-edgar","filing":"0001062993-22-019752","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000106299322019752/form4.xml","form_type":"4"}},{"id":2166062,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2022-09-06T21:04:49.000Z","date":"2022-09-01","kind":"sale","acquired":false,"shares":11346,"price":11.2958,"value":128162.1468,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.96 to $11.57 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":867365,"source":{"system":"sec-edgar","filing":"0001209191-22-048794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122048794/doc4.xml","form_type":"4"}},{"id":2182299,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2022-08-17T21:23:15.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":10468,"price":12.2836,"value":128584.7248,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.12 to $12.42 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":878711,"source":{"system":"sec-edgar","filing":"0001209191-22-046399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122046399/doc4.xml","form_type":"4"}},{"id":2196073,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2022-08-04T00:37:08.000Z","date":"2022-08-01","kind":"sale","acquired":false,"shares":11346,"price":9.962,"value":113028.852,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $9.75 to $10.23 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":889179,"source":{"system":"sec-edgar","filing":"0001209191-22-044343","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122044343/doc4.xml","form_type":"4"}},{"id":2205523,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-07-19T21:02:14.000Z","date":"2022-07-15","kind":"sale","acquired":false,"shares":10468,"price":10.8592,"value":113674.1056,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.73 to $11.04 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":900525,"source":{"system":"sec-edgar","filing":"0001209191-22-042597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122042597/doc4.xml","form_type":"4"}},{"id":2212370,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-07-07T00:20:12.000Z","date":"2022-07-01","kind":"sale","acquired":false,"shares":11346,"price":10.7824,"value":122337.1104,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.57 to $10.97 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":910993,"source":{"system":"sec-edgar","filing":"0001209191-22-041399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122041399/doc4.xml","form_type":"4"}},{"id":2228374,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-06-17T21:46:30.000Z","date":"2022-06-15","kind":"sale","acquired":false,"shares":10468,"price":8.0091,"value":83839.2588,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $8.00 to $8.05 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":922339,"source":{"system":"sec-edgar","filing":"0001209191-22-038009","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122038009/doc4.xml","form_type":"4"}},{"id":2229943,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T22:24:27.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":7688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 14, 2022 with respect to 7,688 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":7688,"derivative":{"exercise_price":38.49,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":7688},"source":{"system":"sec-edgar","filing":"0001209191-22-037592","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919122037592/doc4.xml","form_type":"4"}},{"id":2229942,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T22:24:27.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":5197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":7291,"source":{"system":"sec-edgar","filing":"0001209191-22-037592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919122037592/doc4.xml","form_type":"4"}},{"id":2240511,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-06-07T22:09:10.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":11346,"price":8,"value":90768.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":932807,"source":{"system":"sec-edgar","filing":"0001209191-22-034894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122034894/doc4.xml","form_type":"4"}},{"id":2242398,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-06T20:01:36.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":11918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) the one-year anniversary of June 2, 2022 (the \"Vesting Start Date\") or (ii) the Issuer's next annual meeting of stockholders."}],"balance_after":11918,"derivative":{"exercise_price":6.06,"expiration_date":"2032-06-02","underlying":"Common Stock","underlying_shares":11918},"source":{"system":"sec-edgar","filing":"0001104659-22-068501","document":"tm2217670-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689375/000110465922068501/tm2217670-2_4seq1.xml","form_type":"4"}},{"id":2256980,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-05-25T21:18:42.000Z","date":"2022-05-23","kind":"sale","acquired":false,"shares":21814,"price":8.0025,"value":174566.535,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $8.00 to $8.02 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":944153,"source":{"system":"sec-edgar","filing":"0001209191-22-031930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122031930/doc4.xml","form_type":"4"}},{"id":2294128,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-04-20T21:39:41.000Z","date":"2022-04-19","kind":"sale","acquired":false,"shares":8254,"price":8.0061,"value":66082.3494,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $8.00 to $8.03 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":965967,"source":{"system":"sec-edgar","filing":"0001209191-22-025052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122025052/doc4.xml","form_type":"4"}},{"id":2294127,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-04-20T21:39:41.000Z","date":"2022-04-18","kind":"sale","acquired":false,"shares":2214,"price":8.0371,"value":17794.1394,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $8.00 to $8.15 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":974221,"source":{"system":"sec-edgar","filing":"0001209191-22-025052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122025052/doc4.xml","form_type":"4"}},{"id":2432524,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Stock Options (right to buy)","published_at":"2022-01-19T23:43:51.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":438222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options vest and become exercisable in a series of installments over a four year period, with 25% vesting on January 3, 2023 and the remaining 75% vesting ratably each month thereafter."}],"balance_after":438222,"derivative":{"exercise_price":12.11,"expiration_date":"2032-01-14","underlying":"Common Stock","underlying_shares":438222},"source":{"system":"sec-edgar","filing":"0001209191-22-003820","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122003820/doc4.xml","form_type":"4"}},{"id":2432523,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-01-19T23:43:51.000Z","date":"2022-01-18","kind":"sale","acquired":false,"shares":8564,"price":10.23,"value":87609.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":976435,"source":{"system":"sec-edgar","filing":"0001209191-22-003820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122003820/doc4.xml","form_type":"4"}},{"id":2432522,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-01-19T23:43:51.000Z","date":"2022-01-14","kind":"tax_withholding","acquired":false,"shares":58891,"price":10.53,"value":620122.23,"ownership":{"direct":true},"balance_after":984999,"source":{"system":"sec-edgar","filing":"0001209191-22-003820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122003820/doc4.xml","form_type":"4"}},{"id":2432521,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-01-19T23:43:51.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":149660,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Granted for the achievement of the 2019 PRSU TSR goal as determined by the Board of Directors."}],"balance_after":1043890,"source":{"system":"sec-edgar","filing":"0001209191-22-003820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122003820/doc4.xml","form_type":"4"}},{"id":2432520,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-01-19T23:43:51.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":239099,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Granted in the form of Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Restricted Stock Units will vest in four equal annual installments beginning on January 3, 2023."}],"balance_after":894230,"source":{"system":"sec-edgar","filing":"0001209191-22-003820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122003820/doc4.xml","form_type":"4"}},{"id":2436000,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-14T00:53:53.000Z","date":"2022-01-12","kind":"purchase","acquired":true,"shares":5000,"price":9.715,"value":48575.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001104659-22-004129","document":"tm222967-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689375/000110465922004129/tm222967-1_4seq1.xml","form_type":"4"}},{"id":2440329,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-01-07T22:20:26.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":63543,"price":12.1826,"value":774118.9518,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Comprised of 46,910 shares received from the 2019 PRSU grant, awarded for exceeding the Galafold revenue goal for the applicable measurement period, and 16,333 shares received from the 2018 annual grant, the receipt of which were deferred by Mr. Crowley until January 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.95 to $12.59 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":655131,"source":{"system":"sec-edgar","filing":"0001209191-22-002472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122002472/doc4.xml","form_type":"4"}},{"id":2450129,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-01-05T02:06:36.000Z","date":"2022-01-04","kind":"tax_withholding","acquired":false,"shares":11336,"price":12.48,"value":141473.28,"ownership":{"direct":true},"balance_after":718674,"source":{"system":"sec-edgar","filing":"0001209191-22-001221","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122001221/doc4.xml","form_type":"4"}},{"id":2450128,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-01-05T02:06:36.000Z","date":"2022-01-03","kind":"tax_withholding","acquired":false,"shares":40069,"price":12.11,"value":485235.59,"ownership":{"direct":true},"balance_after":730010,"source":{"system":"sec-edgar","filing":"0001209191-22-001221","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122001221/doc4.xml","form_type":"4"}},{"id":2450127,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-01-05T02:06:36.000Z","date":"2022-01-02","kind":"tax_withholding","acquired":false,"shares":22968,"price":11.55,"value":265280.4,"ownership":{"direct":true},"balance_after":770079,"source":{"system":"sec-edgar","filing":"0001209191-22-001221","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122001221/doc4.xml","form_type":"4"}},{"id":2450126,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2022-01-05T02:06:36.000Z","date":"2021-12-31","kind":"tax_withholding","acquired":false,"shares":31479,"price":11.55,"value":363582.45,"ownership":{"direct":true},"balance_after":793047,"source":{"system":"sec-edgar","filing":"0001209191-22-001221","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919122001221/doc4.xml","form_type":"4"}},{"id":2508053,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Stock Options (right to buy)","published_at":"2021-11-18T00:30:08.000Z","date":"2021-11-15","kind":"exercise","acquired":false,"shares":24935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of these options were fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":4.38,"expiration_date":"2022-06-04","underlying":"Common Stock","underlying_shares":24935},"source":{"system":"sec-edgar","filing":"0001209191-21-065296","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121065296/doc4.xml","form_type":"4"}},{"id":2508052,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2021-11-18T00:30:08.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":24935,"price":11.7486,"value":292951.341,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":824526,"source":{"system":"sec-edgar","filing":"0001209191-21-065296","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121065296/doc4.xml","form_type":"4"}},{"id":2508051,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2021-11-18T00:30:08.000Z","date":"2021-11-15","kind":"exercise","acquired":true,"shares":24935,"price":4.38,"value":109215.3,"ownership":{"direct":true},"balance_after":849461,"source":{"system":"sec-edgar","filing":"0001209191-21-065296","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121065296/doc4.xml","form_type":"4"}},{"id":2526834,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Stock Options (right to buy)","published_at":"2021-11-03T22:30:32.000Z","date":"2021-11-03","kind":"exercise","acquired":false,"shares":27739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of these options were fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":3.82,"expiration_date":"2024-06-24","underlying":"Common Stock","underlying_shares":27739},"source":{"system":"sec-edgar","filing":"0001209191-21-062794","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121062794/doc4.xml","form_type":"4"}},{"id":2526833,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2021-11-03T22:30:32.000Z","date":"2021-11-03","kind":"sale","acquired":false,"shares":27739,"price":12,"value":332868.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":824526,"source":{"system":"sec-edgar","filing":"0001209191-21-062794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121062794/doc4.xml","form_type":"4"}},{"id":2526832,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2021-11-03T22:30:32.000Z","date":"2021-11-03","kind":"exercise","acquired":true,"shares":27739,"price":3.82,"value":105962.98,"ownership":{"direct":true},"balance_after":852265,"source":{"system":"sec-edgar","filing":"0001209191-21-062794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121062794/doc4.xml","form_type":"4"}},{"id":2526831,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2021-11-03T22:30:32.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":7819,"price":10.8007,"value":84450.6733,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.45 to $10.94 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":824526,"source":{"system":"sec-edgar","filing":"0001209191-21-062794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121062794/doc4.xml","form_type":"4"}},{"id":2530724,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-01T22:57:07.000Z","date":"2021-10-28","kind":"grant","acquired":true,"shares":11918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) the one-year anniversary of October 28, 2021 (the \"Vesting Start Date\") or (ii) the Issuer's next annual meeting of stockholders."}],"balance_after":11918,"derivative":{"exercise_price":20,"expiration_date":"2031-10-28","underlying":"Common stock","underlying_shares":11918},"source":{"system":"sec-edgar","filing":"0001104659-21-132474","document":"tm2131250-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689375/000110465921132474/tm2131250-16_4seq1.xml","form_type":"4"}},{"id":2540763,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Stock Options (right to buy)","published_at":"2021-10-19T01:42:02.000Z","date":"2021-10-15","kind":"exercise","acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of these options were fully vested and exercisable as of the transaction date."}],"balance_after":24935,"derivative":{"exercise_price":4.38,"expiration_date":"2022-06-04","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-21-060811","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121060811/doc4.xml","form_type":"4"}},{"id":2540762,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2021-10-19T01:42:02.000Z","date":"2021-10-15","kind":"sale","acquired":false,"shares":22000,"price":11.2214,"value":246870.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.09 to $11.52 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":832345,"source":{"system":"sec-edgar","filing":"0001209191-21-060811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121060811/doc4.xml","form_type":"4"}},{"id":2540761,"issuer":{"id":51196,"kind":"organization","name":"AMICUS THERAPEUTICS, INC.","symbol":"FOLD"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2021-10-19T01:42:02.000Z","date":"2021-10-15","kind":"exercise","acquired":true,"shares":22000,"price":4.38,"value":96360.0,"ownership":{"direct":true},"balance_after":854345,"source":{"system":"sec-edgar","filing":"0001209191-21-060811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178879/000120919121060811/doc4.xml","form_type":"4"}},{"id":2543401,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-10-13T20:15:27.000Z","date":"2021-10-11","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award was issued pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan and had vested as to 12,666 shares as of October 11, 2021."}],"balance_after":25500,"derivative":{"exercise_price":18.83,"expiration_date":"2030-10-01","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-21-060359","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919121060359/doc4.xml","form_type":"4"}},{"id":2543400,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":93014,"kind":"person","name":"Crowley John F","position":1,"cik":"0001400973","reported_name":"Crowley John F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-13T20:15:27.000Z","date":"2021-10-11","kind":"sale","acquired":false,"shares":2500,"price":119.55,"value":298875.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":2094,"source":{"system":"sec-edgar","filing":"0001209191-21-060359","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919121060359/doc4.xml","form_type":"4"}}],"next_cursor":"2021-10-13T20:15:27.000000Z,2543400"}